1
|
Different membrane anchoring positions of tryptophan and lysine in synthetic transmembrane alpha-helical peptides.
|
J Biol Chem
|
1999
|
2.44
|
2
|
Sensitivity of single membrane-spanning alpha-helical peptides to hydrophobic mismatch with a lipid bilayer: effects on backbone structure, orientation, and extent of membrane incorporation.
|
Biochemistry
|
2001
|
1.64
|
3
|
A myristoylated pseudosubstrate peptide, a novel protein kinase C inhibitor.
|
J Biol Chem
|
1993
|
1.58
|
4
|
Inhibition of protein kinase C by tamoxifen.
|
Cancer Res
|
1985
|
1.56
|
5
|
Specificity and function of the individual amino acids of an important determinant of human immunodeficiency virus type 1 that induces neutralizing activity.
|
J Gen Virol
|
1989
|
1.41
|
6
|
Computer-assisted molecular modeling of tumor promoters: rationale for the activity of phorbol esters, teleocidin B, and aplysiatoxin.
|
Proc Natl Acad Sci U S A
|
1986
|
1.05
|
7
|
Triphenylethylenes: a new class of protein kinase C inhibitors.
|
J Natl Cancer Inst
|
1986
|
1.05
|
8
|
Wedgelike glycodendrimers as inhibitors of binding of mammalian galectins to glycoproteins, lactose maxiclusters, and cell surface glycoconjugates.
|
Chembiochem
|
2001
|
1.02
|
9
|
Structure of glycosylated and unglycosylated gag and gag-pol precursor proteins of Moloney murine leukemia virus.
|
J Virol
|
1983
|
1.00
|
10
|
Inhibition of neutrophil NADPH oxidase assembly by a myristoylated pseudosubstrate of protein kinase C.
|
J Biol Chem
|
1993
|
0.99
|
11
|
Structure-activity relationships of sparsomycin and its analogues. Inhibition of peptide bond formation in cell-free systems and of L1210 and bacterial cell growth.
|
J Med Chem
|
1987
|
0.87
|
12
|
Comparing mass spectrometric characteristics of peptides and peptoids.
|
Rapid Commun Mass Spectrom
|
1996
|
0.85
|
13
|
Inhibition of protein kinase C and calmodulin by the geometric isomers cis- and trans-tamoxifen.
|
Biopolymers
|
1990
|
0.85
|
14
|
Synthesis of a substrate of protein kinase C and its corresponding phosphopeptide.
|
Int J Pept Protein Res
|
1989
|
0.82
|
15
|
Inhibition of IL-2 receptor induction and IL-2 production in the human leukemic cell line Jurkat by a novel peptide inhibitor of protein kinase C.
|
Cell Immunol
|
1990
|
0.82
|
16
|
Cellular uptake and localization of fluorescent derivatives of phorbol ester tumor promoters.
|
Biochem Biophys Res Commun
|
1985
|
0.82
|
17
|
Synthesis of cyclic peptides by ring-closing metathesis.
|
J Org Chem
|
2000
|
0.81
|
18
|
Peptoid - peptide hybrids that bind Syk SH2 domains involved in signal transduction.
|
Chembiochem
|
2001
|
0.80
|
19
|
Combinatorial chemistry of hydantoins.
|
Bioorg Med Chem Lett
|
1998
|
0.80
|
20
|
TNF-mediated cytotoxicity of L929 cells: role of staurosporine in enhancement of cytotoxicity and translocation of protein kinase C isozymes.
|
Cytokine
|
1997
|
0.80
|
21
|
A novel N-myristylated synthetic octapeptide inhibits protein kinase C activity and partially reverses murine fibrosarcoma cell resistance to adriamycin.
|
Invest New Drugs
|
1991
|
0.79
|
22
|
Solid-phase synthesis of oligourea peptidomimetics employing the Fmoc protection strategy.
|
J Org Chem
|
2001
|
0.78
|
23
|
A versatile method for the conjugation of proteins and peptides to poly[2-(dimethylamino)ethyl methacrylate].
|
Bioconjug Chem
|
1999
|
0.78
|
24
|
Molecular diversity of peptidomimetics: approaches to the solid-phase synthesis of peptidosulfonamides.
|
Bioorg Med Chem
|
1996
|
0.78
|
25
|
Regulation of CD3 expression in a protein kinase C isozyme-deficient T-cell line.
|
Immunology
|
1993
|
0.77
|
26
|
Increased stability of peptidesulfonamide peptidomimetics towards protease catalyzed degradation.
|
Bioorg Med Chem
|
1999
|
0.76
|
27
|
N-myristyl-Lys-Arg-Thr-Leu-Arg: a novel protein kinase C inhibitor.
|
Biochem Pharmacol
|
1990
|
0.76
|
28
|
A selectively deprotectable triazacyclophane scaffold for the construction of artificial receptors.
|
Org Lett
|
2001
|
0.75
|
29
|
Structure-activity relationships of sparsomycin and its analogues. Octylsparsomycin: the first analogue more active than sparsomycin.
|
J Med Chem
|
1984
|
0.75
|
30
|
Verification of the position of the phosphate group in some synthetic phosphopeptides by fast-atom bombardment and tandem mass spectrometry.
|
Rapid Commun Mass Spectrom
|
1993
|
0.75
|
31
|
Computer-aided molecular modeling and design of DNA-inserting molecules.
|
J Comput Aided Mol Des
|
1992
|
0.75
|
32
|
Determination of sparsomycin in plasma and urine of the dog by means of reversed-phase high-performance liquid chromatography and first pharmacokinetic results.
|
J Chromatogr
|
1983
|
0.75
|
33
|
Sulfoxide configuration in sparsomycin determines time-dependent and competitive inhibition of peptidyl transferase.
|
Biochem Biophys Res Commun
|
1984
|
0.75
|
34
|
Bio-inspired synthetic receptor molecules towards mimicry of vancomycin.
|
Bioorg Med Chem Lett
|
2001
|
0.75
|
35
|
Peptides containing the sulfonamide transition-state isostere: synthesis and structure of N-acetyl-tauryl-L-proline methylamide.
|
Int J Pept Protein Res
|
1995
|
0.75
|